Indivior Pharmaceuticals, Inc. INDV
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-06-12
Indivior Pharmaceuticals, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 4,595,535 | $140.1M |
| CITADEL ADVISORS LLC | 3,705,044 | $112.9M |
| AQR CAPITAL MANAGEMENT LLC | 304,202 | $9.3M |
| D. E. Shaw & Co., Inc. | 203,985 | $6.2M |
| TWO SIGMA INVESTMENTS, LP | 175,767 | $5.4M |
| Point72 Asset Management, L.P. | 94,943 | $2.9M |
| Bridgewater Associates, LP | 37,141 | $1.1M |
Source: SEC EDGAR filings · CIK 0001625297 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.